Analysis of the Immunogenicity of Mrna-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated with Cyclin-Dependent Kinases 4 and 6 Inhibitors (cdki): Limited T-Cell Immunity Despite Satisfactory Humoral Response.
openalex（2021）
Key words
Cancer Immunotherapy,Cancer Immunoediting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined